You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FDHT

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Breast Carcinoma, Metastatic Breast Cancer Trial in New York (18F-FDG PET/CT, [18F]-Fluoro-2-Deoxy-D-Glucose and

Recruiting
  • Breast Cancer
  • +4 more
  • 18F-FDG PET/CT
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 17, 2023

Prostate Cancer Trial in Vienna (FDHT-PET Scan, liquid biopsies)

Recruiting
  • Prostate Cancer
  • FDHT-PET Scan
  • liquid biopsies
  • Vienna, Austria
    Medical University of Vienna
Feb 4, 2022

Prostate Cancer Trial in Vienna (PSMA PET Scan, FDHT PET Scan)

Recruiting
  • Prostate Cancer
  • PSMA PET Scan
  • FDHT PET Scan
  • Vienna, Austria
    Medical University of Vienna
Oct 25, 2021

Breast Cancer Trial in Groningen (Bicalutamide, FDHT PET)

Completed
  • Breast Cancer
  • Groningen, Netherlands
    University Medical Center Groningen
Nov 26, 2019

Male Breast Cancer Trial in Groningen (AndroGel)

Not yet recruiting
  • Male Breast Cancer
  • Groningen, Netherlands
    UMCG
May 17, 2022

Prostatic Tumors Trial in New York (CC-90011, Abiraterone, Prednisone)

Recruiting
  • Prostatic Neoplasms
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jul 21, 2022

Prostate Cancer Trial in Winston-Salem ([F-18] fluorinated dihydrotestosterone (FDHT))

Terminated
  • Prostate Cancer
  • [F-18] fluorinated dihydrotestosterone (FDHT)
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 2, 2018

Metastatic Castration-Resistant Prostate Cancer Trial in New York (MLN0128)

Completed
Has Results
  • Metastatic Castration-Resistant Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 13, 2019

Prostate Cancer, Localized Prostate Cancer Trial in New York (drug, device, other)

Completed
  • Prostate Cancer
  • Localized Prostate Cancer
  • [18F] DIHYDRO-TESTOSTERONE
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 3, 2018

Metastatic Castrate-resistant Prostate Cancer, Adenocarcinoma, Prostate Trial in United States (TRC253)

Completed
Has Results
  • Metastatic Castrate-resistant Prostate Cancer
  • Adenocarcinoma, Prostate
  • Birmingham, Alabama
  • +4 more
Mar 29, 2021

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (biological,

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Cixutumumab
  • +2 more
  • Chicago, Illinois
  • +3 more
May 21, 2019

Metastatic Breast Cancer Trial in Amsterdam, Groningen (FDHT-PET scan, FES-PET scan, CT-scan)

Completed
  • Metastatic Breast Cancer
  • FDHT-PET scan
  • +4 more
  • Amsterdam, Netherlands
  • +1 more
Sep 14, 2015

Prostate Cancer, Castration-resistant, Metastatic Trial in New York (testosterone (AndroGel®) with the 5a-reductase inhibitor

Completed
  • Prostate Cancer
  • Castration-resistant, Metastatic
  • testosterone (AndroGel®) with the 5α-reductase inhibitor dutasteride
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 28, 2015

Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Ann Arbor (vorinostat, laboratory biomarker analysis)

Completed
Has Results
  • Recurrent Prostate Cancer
  • Stage IV Prostate Cancer
  • Ann Arbor, Michigan
    University of Michigan
Apr 25, 2014